Inventor · disambiguated record
Chiung-Tong Chen
Also filed as: CHEN CHIUNG-TONG
15 granted patents·6 pending applications·28 citations·filing 2002–2024
88Inventor score
Files withNAT HEALTH RESEARCH INSTITUTES10NATIONAL HEALTH RES INST9DEV CT BIOTECHNOLOGY1TUAN TSUNG-FAN1
Top patents by PatentIndex Score
21 records- 0181US6903104B2Indol-3-YL-2-oxoacetamide compounds and methods of use thereofNAT HEALTH RESEARCH INSTITUTES·Filed 2002·Granted Jun 7, 2005·15 cites·15 claims
- 0279US12091454B2Humanized anti-human neurotensin receptor 1 antibodies and their usesDEV CT BIOTECHNOLOGY·Filed 2022·Granted Sep 17, 2024·1 cites·19 claims
- 0379US7396838B2Use of 1H-indol-3-yl-2-oxoacetamide compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2005·Granted Jul 8, 2008·2 cites·8 claims
- 0475US10584120B1Benzimidazole compounds and use thereof for treating Alzheimer's Disease or Huntington's DiseaseNATIONAL HEALTH RES INST·Filed 2019·Granted Mar 10, 2020·1 cites·24 claims
- 0575US9926298B2Heterocyclic compounds and use thereofNATIONAL HEALTH RES INST·Filed 2017·Granted Mar 27, 2018·2 cites·28 claims
- 0674US9862703B2Heterocyclic compounds and use thereofNATIONAL HEALTH RES INST·Filed 2015·Granted Jan 9, 2018·2 cites·26 claims
- 0772US7129359B2Imidazolidinone compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2003·Granted Oct 31, 2006·5 cites·41 claims
- 0866US2025121078A1Peptide drug conjugates and their usesNATIONAL HEALTH RES INST·Filed 2024·Application pending·0 cites
- 0965US7662834B2Methods of 1H-indol-3-yl-2-oxoacetamide compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2008·Granted Feb 16, 2010·0 cites·14 claims
- 1060US7569596B2Imidazolamino compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2006·Granted Aug 4, 2009·0 cites·10 claims
- 1160US7462723B2Imidazolamino compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2006·Granted Dec 9, 2008·0 cites·11 claims
- 1259US2023320987A1Lipid nanoparticles and liposomesNATIONAL HEALTH RES INST·Filed 2023·Application pending·0 cites
- 1358US7501445B2Imidazolidinone compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2006·Granted Mar 10, 2009·0 cites·19 claims
- 1455US2023097801A1Methods of increasing cell phagocytosisNATIONAL HEALTH RES INST·Filed 2022·Application pending·0 cites
- 1554US8026271B2Formulations of indol-3-yl-2-oxoacetamide compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2008·Granted Sep 27, 2011·0 cites·16 claims
- 1653US11878986B2Poly heterocyclic conjugates and their pharmaceutical usesNATIONAL HEALTH RES INST·Filed 2021·Granted Jan 23, 2024·0 cites·15 claims
- 1750US7109227B2Imidazolamino compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2003·Granted Sep 19, 2006·0 cites·13 claims
- 1848US2023131830A1Pyrimidine compounds and their pharmaceutical usesNATIONAL HEALTH RES INST·Filed 2021·Application pending·0 cites
- 1946US2023183357A1Anti-human neurotensin receptor 1 antibody and use thereofNATIONAL HEALTH RES INST·Filed 2021·Application pending·0 cites
- 2045US2009111109A1Genes relating to gastric cancer metastasisTUAN TSUNG-FAN·Filed 2008·Application pending·0 cites
- 2133US9388193B2Dipicolylamine derivatives and their pharmaceutical usesNAT HEALTH RESEARCH INSTITUTES·Filed 2015·Granted Jul 12, 2016·0 cites·23 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →